Abstract
Forty patients with urinary tract infections were randomly assigned to receive a ten-day course of oral therapy with either norfloxacin 400 mg twice daily or cotrimoxazole (trimethoprim-sulfamethoxazole) 160/800 mg twice daily. There were 34 cases (19 in the norfloxacin and 15 in the cotrimoxazole group) of evaluable infections due toEscherichia coli (85 % of cases),Klebsiella pneumoniae, Enterobacter spp.,Proteus vulgaris andAlcaligenes faecalis. All organisms were sensitive to the assigned study drug. Twenty-two strains ofEscherichia coli and five other isolates had a norfloxacin MIC50 of 0.03 mg/l and MIC90 of 1.0 mg/l. All patients were cured of the initial infection. Three diabetic patients in the norfloxacin group and another healthy patient in the cotrimoxazole group experienced asymptomatic recurrences due to organisms of the same species which, in the absence of causes of bacterial persistence, were considered to be reinfections. Mild reversible adverse effects of no clinical significance were observed in nine patients in each treatment group. Norfloxacin seems to be as effective and safe as cotrimoxazole in the conventional treatment of uncomplicated urinary tract infection.
Similar content being viewed by others
References
Levison, M. E., Kaye, D.: Management of urinary tract infection. In: Kaye, D. (ed.): Urinary tract infections and its management. C. V. Mosby Co., St. Louis, 1972, p. 188–226.
Reeves, D. S., Faiers, M. C., Pursell, R. E., Brumfitt, W.: Trimethoprim-sulfamethoxazole: comparative study in urinary infection in hospital. British Medical Journal 1969, i: 541–544.
Brumfitt, W., Pursell, R.: Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection. British Medical Journal 1972, ii: 673–676.
Cosgrove, M. D., Morrow, J. W.: Ampiciliin versus trimethoprim-sulfamethoxazole in chronic urinary tract infection. Journal of Urology 1974, 111: 670–672.
Gadebusch, H. H., Shungu, D. L., Weinberg, E., Chung, S. K.: Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents. Infection 1982, 10: 41–44.
Downs, J., Andriole, V. T., Ryan, J. L.: In-vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistantPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1982, 21: 848–851.
Khan, M. Y., Gruninger, R. P., Nelson, S. M., Klicker, R. E.: Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates. Antimicrobial Agents and Chemotherapy 1982, 21: 848–851.
Investigator's Brochure: MK-0366. Merck, Sharp & Dohme, Rahway, NJ, 1981.
Bauer, A. W., Kirby, W. M. M., Sherris, J. C., Turck, M.: Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology 1966, 45: 493–496.
National Committee for Clinical Laboratory Standards: Proposed Standard PSM-7: Standard methods for dilution antimicrobial susceptibility test for bacteria which grow aerobically. Villanova, PA, 1980.
Thomas, V. L., Shelokov, A., Forland, M.: Antibody-coated bacteria in the urine and the site of urinary tract infection. New England Journal of Medicine 1974, 290: 588–590.
Stamey, T. A.: Urinary tract infections in the female: a perspective. In: Remington, J. S., Swartz, M. N. (ed.): Infectious diseases, No. 2, McGraw-Hill, New York, 1981, p. 31–53.
Forland, M., Thomas, V., Shelokov, A.: Urinary tract infections in patients with diabetes mellitus. Studies on antibody-coated bacteria. Journal of the American Medical Association 1977, 238: 1924–1926.
Bailey, R. R., Abbott, G. D.: Treatment of urinary tract infection with a single dose of trimethoprimsulfamethoxazole. Canadian Medical Association Journal 1978, 118: 551–552.
Tolkoff-Rubin, N. R., Weber, D., Fang, L. S. T., Kelly, M., Wilkonson, R., Rubin, R. H.: Single dose therapy with trimethoprim-sulfamethoxazole for urinary tract infection in women. Review of Infectious Diseases 1982, 4: 444–446.
Fang, L. S. T., Tolkoff-Rubin, N. E., Rubin, R. H.: Localization and antibiotic management of urinary tract infection. Annual Review of Medicine 1979, 30: 225–239.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guerra, J.G., Falconi, E., Palomino, J.C. et al. Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections. Eur. J. Clin. Microbiol. 2, 260–265 (1983). https://doi.org/10.1007/BF02029529
Issue Date:
DOI: https://doi.org/10.1007/BF02029529